Intracerebroventricular leptin administration differentially alters cardiac energy metabolism in mice fed a low-fat and high-fat diet

Journal of Cardiovascular Pharmacology

Volumn 57, Issue 1, 2011, Pages 103-113

  Keung, Wendy ^a   Cadete, Virgilio J J ^a   Palaniyappan, Arivazhagan ^a   Jablonski, Amissa ^a   Fischer, Melanie ^a   Lopaschuk, Gary D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

fatty acid oxidation; glucose oxidation; Leptin; malonyl CoA; pyruvate dehydrogenase

Indexed keywords

LEPTIN; MALONYL COENZYME A; PYRUVATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COENZYME; CONTROLLED STUDY; DRY WEIGHT; ENERGY METABOLISM; ENZYME ACTIVITY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GLUCOSE METABOLISM; GLUCOSE OXIDATION; HEART FUNCTION; HEART MUSCLE METABOLISM; LIPID DIET; LIPID METABOLISM; LOW FAT DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE LEVEL; WEIGHT GAIN;

ANIMALS; BODY WEIGHT; CARBOXY-LYASES; DIETARY FATS; ENERGY INTAKE; ENERGY METABOLISM; GLUCOSE; HYPOTHALAMUS; INFUSIONS, INTRAVENTRICULAR; LEPTIN; LIPID METABOLISM; MALE; MALONYL COENZYME A; MICE; MICE, INBRED C57BL; MICE, OBESE; MYOCARDIUM; OBESITY; OXIDATION-REDUCTION; RANDOM ALLOCATION;

EID: 78951481202     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31820014f9     Document Type: Article

References (66)

1. Wild SH, Byrne CD. ABC of obesity. Risk factors for diabetes and coronary heart disease. BMJ. 2006;333:1009-1011.
2. Wilson PW, D'Agostino RB, Sullivan L, et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162:1867-1872.
3. Barouch LA, Berkowitz DE, Harrison RW, et al. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation. 2003;108:754-759.
4. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305-313.
5. Zhou YT, Grayburn P, Karim A, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A. 2000;97: 1784-1789.
6. Park SY, Cho YR, Kim HJ, et al. Unraveling the temporal pattern of dietinduced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes. 2005;54:3530-3540.
7. Aasum E, Belke DD, Severson DL, et al. Cardiac function and metabolism in type 2 diabetic mice after treatment with BM 17.0744, a novel PPARalpha activator. Am J Physiol Heart Circ Physiol. 2002;283:H949-H957.
8. Harmancey R, Wilson CR, Taegtmeyer H. Adaptation and maladaptation of the heart in obesity. Hypertension. 2008;52:181-187.
9. Boden G. Obesity and free fatty acids. Endocrinol Metab Clin North Am. 2008;37:635-646, viii-ix.
10. Buchanan J, Mazumder PK, Hu P, et al. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology. 2005;146:5341-5349.
11. Koutsari C, Jensen MD. Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity. J Lipid Res. 2006;47:1643-1650.
12. Mazumder PK, O'Neill BT, Roberts MW, et al. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes. 2004;53:2366-2374.
13. Lin Y, Itani SI, Kurowski TG, et al. Inhibition of insulin signaling and glycogen synthesis by phorbol dibutyrate in rat skeletal muscle. Am J Physiol Endocrinol Metab. 2001;281:E8-E15.
14. Summers SA, Garza LA, Zhou H, et al. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol. 1998;18:5457-5464.
15. Young ME, Guthrie PH, Razeghi P, et al. Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes. 2002;51:2587-2595.
16. Belke DD, Larsen TS, Gibbs EM, et al. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol Endocrinol Metab. 2000;279:E1104-E1113.
17. Burkhoff D, Weiss RG, Schulman SP, et al. Influence of metabolic substrate on rat heart function and metabolism at different coronary flows. Am J Physiol. 1991;261:H741-H750.
18. Lopaschuk GD, Folmes CD, Stanley WC. Cardiac energy metabolism in obesity. Circ Res. 2007;101:335-347.
19. Randle PJ, Garland PB, Hales CN, et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785-789.
20. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85:1093-1129.
21. Liu B, Clanachan AS, Schulz R, et al. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. Circ Res. 1996; 79:940-948.
22. Liu B, el Alaoui-Talibi Z, Clanachan AS, et al. Uncoupling of contractile function from mitochondrial TCS cycle activity and MVO2 during reperfusion of ischemic hearts. Am J Physiol. 1996;270:H72-H80.
23. Liu Q, Docherty JC, Rendell JC, et al. High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation. J Am Coll Cardiol. 2002;39:718-725.
24. Schwartz MW, Woods SC, Porte D Jr, et al. Central nervous system control of food intake. Nature. 2000;404:661-671.
25. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763-770.
26. Muoio DM, Dohm GL, Fiedorek FT Jr, et al. Leptin directly alters lipid partitioning in skeletal muscle. Diabetes. 1997;46:1360-1363.
27. Minokoshi Y, Kahn BB. Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle. Biochem Soc Trans. 2003;31:196-201.
28. Minokoshi Y, Kim YB, Peroni OD, et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature. 2002;415: 339-343.
29. Hulver MW, Berggren JR, Cortright RN, et al. Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab. 2003;284: E741-E747.
30. Steinberg GR, Rush JW, Dyck DJ. AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment. Am J Physiol Endocrinol Metab. 2003;284:E648-E654.
31. Steinberg GR, Michell BJ, van Denderen BJ, et al. Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab. 2006;4:465-474.
32. Finck BN, Lehman JJ, Leone TC, et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest. 2002;109:121-130.
33. Atkinson LL, Fischer MA, Lopaschuk GD. Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis. J Biol Chem. 2002; 277:29424-29430.
34. Kleinridders A, Schenten D, Konner AC, et al. Myd88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab. 2009;10:249-259.
35. Prpic V, Watson PM, Frampton IC, et al. Differential mechanisms and development of leptin resistance in A/J versus C57BL/6J mice during diet-induced obesity. Endocrinology. 2003;144:1155-1163
36. Larsen TS, Belke DD, Sas R, et al. The isolated working mouse heart: methodological considerations. Pflugers Arch. 1999;437:979-985.
37. Barr RL, Lopaschuk GD. Direct measurement of energy metabolism in the isolated working rat heart. J Pharmacol Toxicol Methods. 1997;38: 11-17.
38. Lopaschuk GD, Witters LA, Itoi T, et al. Acetyl-CoA carboxylase involvement in the rapid maturation of fatty acid oxidation in the newborn rabbit heart. J Biol Chem. 1994;269:25871-25878.
39. King MT, Reiss PD, Cornell NW. Determinatio of short-chain coenzyme A compounds by reversed-phase high-performance liquid chromatography. Methods Enzymol. 1988;166:70-79.
40. Riedel MJ, Baczko I, Searle GJ, et al. Metabolic regulation of sodium-calcium exchange by intracellular acyl CoAs. EMBO J. 2006;25:4605-4614.
41. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957; 226:497-509.
42. Burcelin R, Kamohara S, Li J, et al. Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice. Diabetes. 1999;48:1264-1269.
43. Minokoshi Y, Alquier T, Furukawa N, et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature. 2004;428:569-574.
44. Martin TL, Alquier T, Asakura K, et al. Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle. J Biol Chem. 2006; 281:18933-18941.
45. Bence KK, Delibegovic M, Xue B, et al. Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med. 2006;12:917-924.
46. Ussher JR, Koves TR, Jaswal JS, et al. Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase. Diabetes. 2009;58:1766-1775.
47. Soltys CL, Buchholz L, Gandhi M, et al. Phosphorylation of cardiac protein kinase B is regulated by palmitate. Am J Physiol Heart Circ Physiol. 2002;283:H1056-H1064.
48. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998;31:409-414.
49. Roman EA, Reis D, Romanatto T, et al. Central leptin action improves skeletal muscle AKT, AMPK, and PGC1alpha activation by hypothalamic PI3K-dependent mechanism. Mol Cell Endocrinol. 2010;314:62-69.
50. Duan C, Li M, Rui L. Sh2-b promotes insulin receptor substrate 1 (IRS1)- and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin. J Biol Chem. 2004;279:43684-43691.
51. 2+. Biochem J. 1984;218:235-247.
52. McCormack JG, Denton RM. Influence of calcium ions on mammalian intramitochondrial dehydrogenases. Methods Enzymol. 1989;174:95-118.
53. Linn TC, Pettit FH, Reed LJ. Alpha-keto acid dehydrogenase complexes. X. Regulation of the activity of the pyruvate dehydrogenase complex from beef kidney mitochondria by phosphorylation and dephosphorylation. Proc Natl Acad Sci U S A. 1969;62:234-241.
54. Wu P, Peters JM, Harris RA. Adaptive increase in pyruvate dehydrogenase kinase 4 during starvation is mediated by peroxisome proliferator-activated receptor alpha. Biochem Biophys Res Commun. 2001;287:391-396.
55. Wu P, Sato J, Zhao Y, et al. Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart. Biochem J. 1998; 329(pt 1):197-201.
56. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferatoractivated receptors alpha and delta. Proc Natl Acad Sci U S A. 1997;94: 4312-4317.
57. Huang B, Wu P, Bowker-Kinley MM, et al. Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin. Diabetes. 2002;51: 276-283.
58. King KL, Okere IC, Sharma N, et al. Regulation of cardiac malonyl-CoA content and fatty acid oxidation during increased cardiac power. Am J Physiol Heart Circ Physiol. 2005;289:H1033-H1037.
59. Goodwin GW, Taegtmeyer H. Regulation of fatty acid oxidation of the heart by MCD and ACC during contractile stimulation. Am J Physiol. 1999;277:E772-E777.
60. Kudo N, Barr AJ, Barr RL, et al. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5#-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem. 1995;270: 17513-17520.
61. Dyck JR, Barr AJ, Barr RL, et al. Characterization of cardiac malonyl- CoA decarboxylase and its putative role in regulating fatty acid oxidation. Am J Physiol. 1998;275:H2122-H2129.
62. Lee GY, Kim NH, Zhao ZS, et al. Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level. Biochem J. 2004;378:983-990.
63. Buettner C, Muse ED, Cheng A, et al. Leptin controls adipose tissue lipogenesis via central, stat3-independent mechanisms. Nat Med. 2008; 14:667-675.
64. Somoza B, Guzman R, Cano V, et al. Induction of cardiac uncoupling protein-2 expression and adenosine 5#-monophosphate-activated protein kinase phosphorylation during early states of diet-induced obesity in mice. Endocrinology. 2007;148:924-931.
65. Hirosumi J, Tuncman G, Chang L, et al. A central role for JNK in obesity and insulin resistance. Nature. 2002;420:333-336.
66. Kim JK, Fillmore JJ, Sunshine MJ, et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest. 2004;114: 823-827.